| GO ID | GO:0042981 |
| Ontology | BP |
| GO Term | regulation of apoptotic process |
| Definition | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ACTN1 | actinin, alpha 1 |
87 | P12814 | chr14: 68,874,143-68,979,440 |
ACTN2 | actinin, alpha 2 |
88 | P35609 | chr1: 236,686,454-236,764,631 |
ACTN4 | actinin, alpha 4 |
81 | O43707 | chr19: 38,647,649-38,731,583 |
AIFM2 | apoptosis inducing factor, mitochondria associated 2 |
84883 | Q9BRQ8 | chr10: 70,098,223-70,132,934 |
ANP32A | acidic nuclear phosphoprotein 32 family member A |
8125 | P39687 | chr15: 68,778,535-68,820,897 |
ANP32E | acidic nuclear phosphoprotein 32 family member E |
81611 | Q9BTT0 | chr1: 150,218,417-150,236,156 |
BAX | BCL2-associated X protein |
581 | Q07812 | chr19: 48,954,815-48,961,798 |
BCL3 | B-cell CLL/lymphoma 3 |
602 | P20749 | chr19: 44,747,705-44,760,044 |
BCL6 | B-cell CLL/lymphoma 6 |
604 | P41182 | chr3: 187,721,377-187,745,727 |
BEX2 | brain expressed X-linked 2 |
84707 | Q9BXY8 | chrX: 103,309,346-103,311,046 |
BID | BH3 interacting domain death agonist |
637 | P55957 | chr22: 17,734,138-17,774,770 |
BIRC3 | baculoviral IAP repeat containing 3 |
330 | Q13489 | chr11: 102,317,450-102,339,403 |
BIRC5 | baculoviral IAP repeat containing 5 |
332 | O15392 | chr17: 78,214,186-78,225,636 |
BMP1 | bone morphogenetic protein 1 |
649 | P13497 | chr8: 22,164,736-22,212,326 |
BMP10 | bone morphogenetic protein 10 |
27302 | O95393 | chr2: 68,865,481-68,871,517 |
BMP15 | bone morphogenetic protein 15 |
9210 | O95972 | chrX: 50,910,784-50,916,607 |
BMP3 | bone morphogenetic protein 3 |
651 | P12645 | chr4: 81,030,965-81,057,531 |
BMP6 | bone morphogenetic protein 6 |
654 | P22004 | chr6: 7,726,797-7,881,422 |
BMP8A | bone morphogenetic protein 8a |
353500 | Q7Z5Y6 | chr1: 39,491,646-39,525,935 |
BMP8B | bone morphogenetic protein 8b |
656 | P34820 | chr1: 39,757,182-39,788,861 |
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like |
665 | O60238 | chr8: 26,382,898-26,505,636 |
BRCA1 | breast cancer 1 |
672 | P38398 | chr17: 43,044,295-43,170,245 |
CALR | calreticulin |
811 | P27797 | chr19: 12,938,578-12,944,489 |
CARD10 | caspase recruitment domain family member 10 |
29775 | Q9BWT7 | chr22: 37,490,362-37,519,542 |
CARD16 | caspase recruitment domain family member 16 |
114769 | Q5EG05 | chr11: 105,041,326-105,101,431 |
CASP1 | caspase 1 |
834 | P29466 | chr11: 105,025,443-105,035,250 |
CASP4 | caspase 4 |
837 | P49662 | chr11: 104,942,866-104,969,436 |
CASP6 | caspase 6 |
839 | P55212 | chr4: 109,688,622-109,703,583 |
CDK5 | cyclin-dependent kinase 5 |
1020 | Q00535 | chr7: 151,053,812-151,058,530 |
CHM | choroideremia (Rab escort protein 1) |
1121 | P24386 | chrX: 85,861,180-86,047,562 |
CRADD | CASP2 and RIPK1 domain containing adaptor with death domain |
8738 | P78560 | chr12: 93,677,375-93,894,840 |
CREBBP | CREB binding protein |
1387 | Q92793 | chr16: 3,725,054-3,880,726 |
CTSB | cathepsin B |
1508 | P07858 | chr8: 11,842,524-11,869,448 |
DAPK1 | death-associated protein kinase 1 |
1612 | P53355 | chr9: 87,497,228-87,708,633 |
DAPK3 | death-associated protein kinase 3 |
1613 | O43293 | chr19: 3,958,453-3,971,123 |
DIP2A | disco interacting protein 2 homolog A |
23181 | Q14689 | chr21: 46,458,899-46,569,852 |
DLG5 | discs, large homolog 5 (Drosophila) |
9231 | Q8TDM6 | chr10: 77,790,791-77,926,526 |
DUSP1 | dual specificity phosphatase 1 |
1843 | P28562 | chr5: 172,768,090-172,771,195 |
EGR1 | early growth response 1 |
1958 | P18146 | chr5: 138,465,490-138,469,315 |
ESR1 | estrogen receptor 1 |
2099 | P03372 | chr6: 151,656,691-152,129,619 |
FAS | Fas cell surface death receptor |
355 | P25445 | chr10: 88,990,582-89,015,785 |
FBXO10 | F-box protein 10 |
26267 | Q9UK96 | chr9: 37,510,892-37,576,349 |
FRS2 | fibroblast growth factor receptor substrate 2 |
10818 | Q8WU20 | chr12: 69,470,349-69,579,789 |
FYN | FYN proto-oncogene, Src family tyrosine kinase |
2534 | P06241 | chr6: 111,660,332-111,873,452 |
GAS1 | growth arrest specific 1 |
2619 | P54826 | chr9: 86,944,363-86,947,189 |
GDF11 | growth differentiation factor 11 |
10220 | O95390 | chr12: 55,743,280-55,757,278 |
GDF15 | growth differentiation factor 15 |
9518 | Q99988 | chr19: 18,374,731-18,389,176 |
GDF5 | growth differentiation factor 5 |
8200 | P43026 | chr20: 35,433,347-35,454,746 |
GDF9 | growth differentiation factor 9 |
2661 | O60383 | chr5: 132,861,181-132,866,884 |
HAX1 | HCLS1 associated protein X-1 |
10456 | O00165 | chr1: 154,272,511-154,275,875 |
HIP1 | huntingtin interacting protein 1 |
3092 | O00291 | chr7: 75,533,300-75,738,962 |
HS1BP3 | HCLS1 binding protein 3 |
64342 | Q53T59 | chr2: 20,560,448-20,651,089 |
IGFBP3 | insulin like growth factor binding protein 3 |
3486 | P17936 | chr7: 45,912,245-45,921,874 |
INHA | inhibin alpha |
3623 | P05111 | chr2: 219,569,162-219,575,713 |
INHBB | inhibin beta B |
3625 | P09529 | chr2: 120,346,143-120,351,808 |
INHBC | inhibin beta C |
3626 | P55103 | chr12: 57,434,760-57,450,828 |
JAK2 | Janus kinase 2 |
3717 | O60674 | chr9: 4,984,390-5,128,183 |
LCMT1 | leucine carboxyl methyltransferase 1 |
51451 | Q9UIC8 | chr16: 25,111,729-25,178,231 |
LGALS1 | lectin, galactoside-binding, soluble, 1 |
3956 | P09382 | chr22: 37,675,608-37,679,806 |
LRP5 | LDL receptor related protein 5 |
4041 | O75197 | chr11: 68,312,609-68,449,275 |
MITF | microphthalmia-associated transcription factor |
4286 | O75030 | chr3: 69,739,435-69,968,337 |
MSTN | myostatin |
2660 | O14793 | chr2: 190,055,697-190,062,729 |
NAE1 | NEDD8 activating enzyme E1 subunit 1 |
8883 | Q13564 | chr16: 66,802,875-66,873,256 |
NDRG1 | N-myc downstream regulated 1 |
10397 | Q92597 | chr8: 133,237,171-133,302,022 |
NGFR | nerve growth factor receptor |
4804 | P08138 | chr17: 49,495,293-49,515,017 |
NME1 | NME/NM23 nucleoside diphosphate kinase 1 |
4830 | P15531 | chr17: 51,153,536-51,162,428 |
NME4 | NME/NM23 nucleoside diphosphate kinase 4 |
4833 | O00746 | chr16: 396,725-410,367 |
PAX8 | paired box 8 |
7849 | Q06710 | chr2: 113,215,997-113,278,950 |
PERP | PERP, TP53 apoptosis effector |
64065 | Q96FX8 | chr6: 138,088,505-138,107,511 |
PHB | prohibitin |
5245 | P35232 | chr17: 49,404,049-49,414,905 |
PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 |
5366 | Q13794 | chr18: 59,899,948-59,904,306 |
PRDX2 | peroxiredoxin 2 |
7001 | P32119 | chr19: 12,796,820-12,801,859 |
PRELID1 | PRELI domain containing 1 |
27166 | Q9Y255 | chr5: 177,303,774-177,306,959 |
RABGGTB | Rab geranylgeranyltransferase, beta subunit |
5876 | P53611 | chr1: 75,786,197-75,795,079 |
RAF1 | Raf-1 proto-oncogene, serine/threonine kinase |
5894 | P04049 | chr3: 12,583,601-12,664,226 |
RASSF3 | Ras association (RalGDS/AF-6) domain family member 3 |
283349 | Q86WH2 | chr12: 64,507,001-64,697,567 |
RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 |
83593 | Q8WWW0 | chr1: 206,507,530-206,589,448 |
RASSF6 | Ras association (RalGDS/AF-6) domain family member 6 |
166824 | Q6ZTQ3 | chr4: 73,571,550-73,620,631 |
RBM25 | RNA binding motif protein 25 |
58517 | P49756 | chr14: 73,058,436-73,123,898 |
RSL1D1 | ribosomal L1 domain containing 1 |
26156 | O76021 | chr16: 11,833,850-11,851,585 |
RTN4 | reticulon 4 |
57142 | Q9NQC3 | chr2: 54,972,187-55,112,621 |
SARM1 | sterile alpha and TIR motif containing 1 |
23098 | Q6SZW1 | chr17: 28,364,356-28,404,049 |
SERBP1 | SERPINE1 mRNA binding protein 1 |
26135 | Q8NC51 | chr1: 67,407,810-67,430,415 |
SGK3 | serum/glucocorticoid regulated kinase family member 3 |
23678 | Q96BR1 | chr8: 66,712,418-66,862,022 |
SKP2 | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
6502 | Q13309 | chr5: 36,151,989-36,184,319 |
SOX9 | SRY-box 9 |
6662 | P48436 | chr17: 72,121,020-72,126,420 |
SRA1 | steroid receptor RNA activator 1 |
10011 | Q9HD15 | chr5: 140,537,340-140,558,252 |
TGFB1 | transforming growth factor beta 1 |
7040 | P01137 | chr19: 41,301,587-41,353,911 |
TMEM219 | transmembrane protein 219 |
124446 | Q86XT9 | chr16: 29,940,885-29,973,052 |
TNFRSF10C | tumor necrosis factor receptor superfamily member 10c |
8794 | O14798 | chr8: 23,084,355-23,117,437 |
TNFRSF11A | tumor necrosis factor receptor superfamily member 11a |
8792 | Q9Y6Q6 | chr18: 62,325,287-62,391,292 |
TNFRSF11B | tumor necrosis factor receptor superfamily member 11b |
4982 | O00300 | chr8: 118,923,557-118,952,200 |
TNFRSF1B | tumor necrosis factor receptor superfamily member 1B |
7133 | P20333 | chr1: 12,167,003-12,209,228 |
TNFRSF21 | tumor necrosis factor receptor superfamily member 21 |
27242 | O75509 | chr6: 47,231,532-47,309,905 |
TNFRSF25 | tumor necrosis factor receptor superfamily member 25 |
8718 | Q93038 | chr1: 6,461,151-6,466,195 |
TP53 | tumor protein p53 |
7157 | P04637 | chr17: 7,661,779-7,687,550 |
TP53BP2 | tumor protein p53 binding protein 2 |
7159 | Q13625 | chr1: 223,779,899-223,845,972 |
TP53INP1 | tumor protein p53 inducible nuclear protein 1 |
94241 | Q96A56 | chr8: 94,925,972-94,949,411 |
TPT1 | tumor protein, translationally-controlled 1 |
7178 | P13693 | chr13: 45,333,471-45,341,370 |
TRIAP1 | TP53 regulated inhibitor of apoptosis 1 |
51499 | O43715 | chr12: 120,443,961-120,446,412 |
VCP | valosin containing protein |
7415 | P55072 | chr9: 35,056,064-35,073,249 |
ZNF420 | zinc finger protein 420 |
147923 | Q8TAQ5 | chr19: 37,007,857-37,130,314 |